Danaher Corporation Announces Board Appointments

Danaher Corporation announced the formation of a Scientific Advisory Board (“Board”) that will help the company protect and grow existing scientific innovations, support the development of new technologies and bring unique perspectives to rapidly emerging science and technology trends. Members of the Board include:

• Angela Caliendo, M.D., Ph.D., Warren Alpert Foundation Professor of Medicine and Executive Vice Chair of Medicine at Alpert Medical School of Brown University.
• President of Brown Physicians Inc. James J. Collins, Ph.D. Termeer Professor of Bioengineering in the Department of Biological Engineering and Institute for Medical Engineering & Science.
• Robert Hershberg, M.D., Ph.D. Venture Partner at Frazier Healthcare Partners.
• Isaac S. Kohane, M.D., Ph.D. Marion V. Nelson Professor of Biomedical Informatics, Harvard Medical School; Chair of the Department of Biomedical Informatics, Harvard Medical School; and Associate Professor of Medicine, Brigham and Women’s Hospital.
• Amy Lynn McGuire, J.D., Ph.D. Leon Jaworski Professor of Biomedical Ethics and Director of the Center for Medical Ethics and Health Policy at Baylor College of Medicine.
• David Rimm, M.D., Ph.D. Professor of Pathology and Medicine, Director of Pathology Tissue Services, and Director of Translational Pathology, Yale School of Medicine. Specializes in Immuno-Oncology, Molecular Pathology methods including NGS and has a strong background with AI-based image analysis in Pathology.
• Phillip A. Sharp, Ph.D. & Nobel Prize Laureate Institute Professor and Professor of Biology, MIT, and Member, Koch Institute for Integrative Cancer Research. Pioneer in the molecular biology of the mechanisms of RNA splicing and its implication for cancer.
• Thomas C. Südhof, M.D. & Nobel Prize Laureate Avram Goldstein Professor Investigator, Howard Hughes Medical Institute; Professor, Dept. of Molecular & Cellular Physiology and Neurosurgery, Professor (by courtesy), Dept. of Neurology & Neurological Sciences and Psychiatry & Behavioral Science, Stanford Medicine.
• David R. Walt, Ph.D. Hansjörg Wyss Professor of Biologically Inspired Engineering, Harvard Medical School; Professor of Pathology at Brigham and Women’s Hospital; Core Faculty of the Wyss Institute at Harvard University; and Howard Hughes Medical Institute Professor. Founder of Illumina and Quanterix.

Danaher Corporation is a medical device company based in Washington, DC. As a global science and technology innovator, Danaher drives meaningful innovation in some of today’s most dynamic industries through its 20 operating companies in four strategic platforms: Life Sciences, Diagnostics, Water Quality, and Product Identification.  As of 2020, its revenue is 22.23 billion USD employing approximately 69,000 people.